You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC / CE

The Power of As-Treated Analyses: What Have We Learned From VEST?

  • Authors: Manesh R. Patel, MD; Ilan Goldenberg, MD
  • CME / ABIM MOC / CE Released: 9/10/2019; Reviewed and Renewed: 11/5/2020
  • THIS ACTIVITY HAS EXPIRED
  • Valid for credit through: 11/5/2021
Start Activity


Target Audience and Goal Statement

This activity is intended for cardiologists, emergency medicine physicians, critical care specialists, and nurses.

The goal of this activity is to improve knowledge regarding clinical trial methodology and data supporting the use of wearable cardioverter-defibrillator (WCD), and the use of effective healthcare provider (HCP)-patient communication strategies to improve prevention of sudden cardiac death (SCD).

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Clinical trial methodology, including the differences between "as treated" vs "intent-to-treat" analyses
    • Clinical data supporting the use of WCD, including randomized clinical trials and real-world evidence
  • Have greater competence related to
    • Use of effective HCP-patient communication strategies to improve SCD prevention 


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Moderator

  • Manesh R. Patel, MD

    Professor of Medicine
    Duke University Medical Center
    Durham, North Carolina

    Disclosures

    Disclosure: Manesh R. Patel, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: AstraZeneca Pharmaceuticals LP; Bayer HealthCare Pharmaceuticals; Janssen Pharmaceuticals, Inc.; Procyrion Inc.
    Received grants for clinical research from: AstraZeneca Pharmaceuticals LP; Bayer HealthCare Pharmaceuticals; Janssen Pharmaceuticals, Inc.; Procyrion Inc.

Faculty

  • Ilan Goldenberg, MD

    Professor of Cardiology
    Director
    Clinical Cardiovascular Research Center
    University of Rochester Medical Center
    Rochester, New York

    Disclosures

    Disclosure: Ilan Goldenberg, MD, has disclosed no relevant financial relationships.

Editor

  • George Boutsalis, PhD

    Senior Medical Education Director, Medscape, LLC

    Disclosures

    Disclosure: George Boutsalis, PhD, has disclosed no relevant financial relationships.

  • Chris Washburn, PhD

    Medical Education Director, Medscape, LLC

    Disclosures

    Disclosure: Chris Washburn, PhD, has disclosed no relevant financial relationships.

  • Asha P. Gupta, PharmD, RPh

    Scientific Content Manager, Medscape, LLC

    Disclosures

    Disclosure: Asha P. Gupta, PharmD, RPh, has disclosed no relevant financial relationships.

CME/CE Reviewers

  • Esther Nyarko, PharmD

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Esther Nyarko, PharmD, has disclosed no relevant financial relationships. 

  • Hazel Dennison, DNP, RN, FNP, CPHQ, CNE

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Hazel Dennison, DNP, RN, FNP, CPHQ, CNE, has disclosed no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed the following relevant financial relationships: Abbott Laboratories


Accreditation Statements


 

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Medscape, LLC staff have disclosed that they have no relevant financial relationships.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

    For Nurses

  • Awarded 0.25 contact hour(s) of continuing nursing education for RNs and APNs; 0 contact hours are in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

The Power of As-Treated Analyses: What Have We Learned From VEST?

Authors: Manesh R. Patel, MD; Ilan Goldenberg, MDFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED

CME / ABIM MOC / CE Released: 9/10/2019; Reviewed and Renewed: 11/5/2020

Valid for credit through: 11/5/2021

processing....

  • Before you begin this activity, please assess your clinical knowledge by completing this brief survey.

  •  
  • Print